The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide

A. Wedzicha, Jadwiga; M.A. Calverley, Peter; Seemungal, Terence; Hagan, Gerry; Ansari, Zainab; A. Stockley, Robert

doi:10.1164/rccm.200707-973oc

Public

The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide

Published in American Journal of Respiratory and Critical Care Medicine • Oct 4, 2007

Authors:

Jadwiga A. Wedzicha

Peter M.A. Calverley

Terence Seemungal

Abstract

RATIONALE: Exacerbations are key drivers of morbidity and mortality in chronic obstructive pulmonary disease (COPD). OBJECTIVES: We compared the relative efficacy of the long-acting inhaled bronchodilator/antiinflammatory combination (salmeterol/fluticasone propionate) 50/500 microg twice daily and ...

Subject

Salmeterol

Fluticasone propionate

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!